Advisor Group Holdings, Inc. Agios Pharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 355 shares of AGIO stock, worth $19,766. This represents 0.0% of its overall portfolio holdings.
Number of Shares
355
Previous 364
2.47%
Holding current value
$19,766
Previous $15,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$315 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$309 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$271 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$208 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$158 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $3.05B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...